EXHIBIT 32.2

                                  CERTIFICATION
                 Pursuant to 18 United States Code Section 1350


      The undersigned hereby certifies that the Quarterly Report on Form 10-Q
for the First Quarter ended March 31, 2004 of Nanobac Pharmaceuticals,
Incorporated (the "Company") filed with the Securities and Exchange Commission
on the date hereof fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended, and that the
information contained in such report fairly presents, in all material respects,
the financial condition and results of operations of the Company.


                                    /s/ John D Stanton
                                    -------------------------------------------
                                    John D Stanton
                                    Chief Financial Officer
                                    May 17, 2004



A signed original of this written statement required by Section 906 has been
provided to Nanobac Pharmaceuticals, Incorporated and will be retained by it and
furnished to the Securities and Exchange Commission or its staff upon request.

This certification accompanies this Report pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the
Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of the
Section 18 of the Securities Exchange Act of 1934, as amended.